Lorazepam Challenge Test

The Lorazepam Challenge Test is a diagnostic procedure in neuropsychiatry that involves the administration of lorazepam to assess the reversibility of motor and behavioral symptoms as a means to confirm the presence of catatonia.

16

Publications

1.1K

Citations

70

Authors

30

Institutions

Publications per year

2017–2026

1

Variants

Lorazepam TestLorazepam Trial

Authors

70

  1. MS
    Mathias Schreckenberger

    Johannes Gutenberg University Mainz, Germany

    2 publications · 215 citations

    2

    h-index

  2. GG
    Gerhard Gründer

    RWTH Aachen University, Germany

    2 publications · 215 citations

    2

    h-index

  3. KM
    Klaus Mann

    Johannes Gutenberg University Mainz, Germany

    2 publications · 215 citations

    2

    h-index

  4. CX
    Christopher X. Wong

    Royal Adelaide Hospital, Australia

    1 publications · 86 citations

    1

    h-index

  5. GS
    Gabriele Schino

    Institute of Cognitive Sciences and Technologies, Italy

    1 publications · 93 citations

    1

    h-index

1–5 of 70

Venues

  1. Psychopharmacology

    2 publications · 41 citations

    2

    h-index

  2. NeuroImage

    1 publications · 193 citations

    1

    h-index

  3. Alcoholism Clinical and Experimental Research

    ACER · 1 publications · 86 citations

    1

    h-index

  4. Journal of Psychopharmacology

    1 publications · 21 citations

    1

    h-index

  5. 1

    h-index

1–5